XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Apr. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of April 30, 2023 (in thousands):

Level 1
Level 2
Total
Cash equivalents:
Money market funds$217,323 $— $217,323 
Commercial paper— 5,951 5,951 
Short-term investments:
Corporate notes and bonds— 1,232,949 1,232,949 
Commercial paper— 937,783 937,783 
U.S. government and agency securities— 686,462 686,462 
Certificates of deposit— 435,320 435,320 
Long-term investments:
Corporate notes and bonds— 654,691 654,691 
U.S. government and agency securities— 436,024 436,024 
Total
$217,323 $4,389,180 $4,606,503 
The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of January 31, 2023 (in thousands):

Level 1
Level 2
Total
Cash equivalents:
Money market funds(1)
$520,138 $— $520,138 
Commercial paper— 9,304 9,304 
Corporate notes and bonds— 6,903 6,903 
Certificates of deposit— 3,044 3,044 
Short-term investments:
Corporate notes and bonds— 1,301,296 1,301,296 
Commercial paper— 881,348 881,348 
Certificates of deposit— 445,194 445,194 
U.S. government and agency securities— 440,128 440,128 
Long-term investments:
Corporate notes and bonds— 801,784 801,784 
U.S. government and agency securities— 263,708 263,708 
Certificates of deposit— 7,531 7,531 
Total(1)
$520,138 $4,160,240 $4,680,378 
________________
(1)Includes a reclassification of $141.0 million from cash to cash equivalents for the money market funds balance as of January 31, 2023, as presented in the Annual Report on Form 10-K filed with the SEC on March 29, 2023. Such reclassification did not impact the Company’s consolidated balance sheet as of January 31, 2023 or its consolidated statement of cash flows for the fiscal year ended January 31, 2023.
Schedule of Fair Value Measurements
The following table presents the Company’s strategic investments by type (in thousands):

April 30, 2023January 31, 2023
Equity securities:
Non-marketable equity securities under Measurement Alternative$176,498 $174,248 
Non-marketable equity securities under equity method5,104 5,066 
Marketable equity securities19,708 22,122 
Debt securities:
Non-marketable debt securities1,500 1,500 
Total strategic investments—included in other assets$202,810 $202,936 
Unrealized Gain (Loss) on Investments
The following table summarizes the unrealized gains and losses included in the carrying value of the Company’s strategic investments in equity securities held as of April 30, 2023 (in thousands):

Three Months Ended April 30,
20232022
Marketable equity securities:
Net unrealized losses$(2,414)$(8,859)
Total—included in other expense, net$(2,414)$(8,859)